Medtronic’s Purchase of SPR Brings Focus to PNS Market
The market for peripheral nerve stimulation systems became significantly more prominent this month with the news that Medtronic intends to purchase SPR Therapeutics for $650 million. Coming on the heels of Boston Scientific’s purchase of Nalu Medical for about $600 million last year, this latest deal has raised the hopes for other PNS upstarts seeking to play in the big leagues with strategic medtech firms.